t.kulkarni
TL3 Regular · Cologne, DE
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 5 December 2024 · last posted 5d
132Posts here
1Topics
3Solutions
3.7kLikes received
2.4kLikes given
23Badges
408Days visited
12kPosts read
Stated areas
Recent activity
Full stream-
Why the timeline is on the right and not the left — what changed since Replied, post #80 · Meta › Site feedback · 23 Jul 2026 · 3 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #94 · Nutrition & Training › Protein & intake · 22 Jul 2026 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
How shortages have affected compounding permissions Replied, post #60 · Access › Shortages · 22 Jul 2026 · 11 likes On post #56 — agreed on the reasoning, with one qualification. Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #28 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 2 likes Worth separating two things that post #24 runs together. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a…
-
Seven-day rolling means and why weekly readings mislead Replied, post #60 · Outcomes › Progress reports · 19 Jul 2026 · 0 likes Worth separating two things that post #56 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #81 · Access › Insurance & coverage · 18 Jul 2026 · 1 like Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
What a certificate commits its issuer to Replied, post #47 · Analytics › COA interpretation · 17 Jul 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Telehealth prescribing models in the US Replied, post #14 · Regional › North America · 13 Jul 2026 · 9 likes Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access.
-
Revisiting: What pooling buys you and what it destroys Replied, post #82 · Evidence › Meta-analyses · 7 Jul 2026 · 4 likes I read post #80 twice before replying, because I had assumed the opposite. Publication bias: what did not get published? Small studies with negative results are less…
-
What a reversed-phase purity number actually is Replied, post #28 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 6 likes post #27 answers the question as asked. The question underneath it is different. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #90 · Practice › Administration · 5 Jul 2026 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #46 · Sourcing › Independent verification · 27 Jun 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…